351 related articles for article (PubMed ID: 12811800)
21. Cholinesterase activity in the hypoglossal nucleus of the rat and the changes produced by axotomy: a light and electron microscopic study.
Flumerfelt BA; Lewis PR
J Anat; 1975 Apr; 119(Pt 2):309-31. PubMed ID: 1133098
[TBL] [Abstract][Full Text] [Related]
22. Choline acetyltransferase immunoreactivity in the rat thalamus.
Levey AI; Hallanger AE; Wainer BH
J Comp Neurol; 1987 Mar; 257(3):317-32. PubMed ID: 3549798
[TBL] [Abstract][Full Text] [Related]
23. Cholinesterases: new roles in brain function and in Alzheimer's disease.
Giacobini E
Neurochem Res; 2003 Apr; 28(3-4):515-22. PubMed ID: 12675140
[TBL] [Abstract][Full Text] [Related]
24. The effects of some porphyrinogenic drugs on the brain cholinergic system.
Rodriguez JA; Buzaleh AM; Fossati M; Azcurra J; Batlle AM
Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):103-10. PubMed ID: 11929041
[TBL] [Abstract][Full Text] [Related]
25. Cyto- and chemoarchitecture of the dorsal thalamus of the monotreme Tachyglossus aculeatus, the short beaked echidna.
Ashwell KW; Paxinos G
J Chem Neuroanat; 2005 Dec; 30(4):161-83. PubMed ID: 16099140
[TBL] [Abstract][Full Text] [Related]
26. Targeting acetylcholinesterase and butyrylcholinesterase in dementia.
Lane RM; Potkin SG; Enz A
Int J Neuropsychopharmacol; 2006 Feb; 9(1):101-24. PubMed ID: 16083515
[TBL] [Abstract][Full Text] [Related]
27. Screening of traditional European herbal medicines for acetylcholinesterase and butyrylcholinesterase inhibitory activity.
Wszelaki N; Kuciun A; Kiss AK
Acta Pharm; 2010 Mar; 60(1):119-28. PubMed ID: 20228046
[TBL] [Abstract][Full Text] [Related]
28. The expression of cholinesterases in human renal tumours varies according to their histological types.
Muñoz-Delgado E; Montenegro MF; Morote-García JC; Campoy FJ; Cabezas-Herrera J; Kovacs G; Vidal CJ
Chem Biol Interact; 2008 Sep; 175(1-3):340-2. PubMed ID: 18482720
[TBL] [Abstract][Full Text] [Related]
29. The interactions of azure B, a metabolite of methylene blue, with acetylcholinesterase and butyrylcholinesterase.
Petzer A; Harvey BH; Petzer JP
Toxicol Appl Pharmacol; 2014 Feb; 274(3):488-93. PubMed ID: 24161345
[TBL] [Abstract][Full Text] [Related]
30. Topographical distribution of acetylcholinesterase and butyrylcholinesterase in the cerebral hemisphere of the garden lizard, Calotes versicolor.
Sethi JS
J Neurosci Res; 1979; 4(1):35-43. PubMed ID: 423314
[TBL] [Abstract][Full Text] [Related]
31. Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease.
Blesa R; Bullock R; He Y; Bergman H; Gambina G; Meyer J; Rapatz G; Nagel J; Lane R
Pharmacogenet Genomics; 2006 Nov; 16(11):771-4. PubMed ID: 17047484
[TBL] [Abstract][Full Text] [Related]
32. Identification of a 17 S asymmetric butyrylcholinesterase in chick muscle by monoclonal antibodies.
Tsim KW; Randall WR; Barnard EA
Neurosci Lett; 1988 Mar; 86(2):245-9. PubMed ID: 3368125
[TBL] [Abstract][Full Text] [Related]
33. Non-cholinergic, trophic action of recombinant acetylcholinesterase on mid-brain dopaminergic neurons.
Holmes C; Jones SA; Budd TC; Greenfield SA
J Neurosci Res; 1997 Jul; 49(2):207-18. PubMed ID: 9272643
[TBL] [Abstract][Full Text] [Related]
34. The level of butyrylcholinesterase activity increases and the content of the mRNA remains unaffected in brain of senescence-accelerated mouse SAMP8.
Fernández-Gómez FJ; Muñoz-Delgado E; Montenegro MF; Campoy FJ; Vidal CJ; Jordán J
Chem Biol Interact; 2008 Sep; 175(1-3):332-5. PubMed ID: 18571151
[TBL] [Abstract][Full Text] [Related]
35. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
Duysen EG; Li B; Darvesh S; Lockridge O
Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
[TBL] [Abstract][Full Text] [Related]
36. Cholinesterase activity in the corpus luteum of the sheep and pig.
Silver A
Indian J Physiol Pharmacol; 1977; 21(4):295-301. PubMed ID: 614277
[TBL] [Abstract][Full Text] [Related]
37. Butyrylcholinesterase activity in multiple sclerosis neuropathology.
Darvesh S; Leblanc AM; Macdonald IR; Reid GA; Bhan V; Macaulay RJ; Fisk JD
Chem Biol Interact; 2010 Sep; 187(1-3):425-31. PubMed ID: 20122907
[TBL] [Abstract][Full Text] [Related]
38. Plasma and red cell cholinesterase activity in uremic patterns (effects of hemodialysis and renal transplantation).
Zarday Z; Deery A; Tellis I; Soberman R; Foldes FF
J Med; 1975; 6(5-6):337-49. PubMed ID: 768397
[TBL] [Abstract][Full Text] [Related]
39. Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles.
Eskander MF; Nagykery NG; Leung EY; Khelghati B; Geula C
Brain Res; 2005 Oct; 1060(1-2):144-52. PubMed ID: 16212945
[TBL] [Abstract][Full Text] [Related]
40. Distribution pattern of cholinesterase enzymes in human tooth germs.
Nandasena TL; Jayawardena CK; Tilakaratne WM; Nanayakkara CD
Arch Oral Biol; 2010 Aug; 55(8):561-9. PubMed ID: 20627235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
